JS207: Clinical Trials

3 trials of JS207, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 recruiting. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Active not recruiting 2, Recruiting 1
Phase 21Recruiting 1

Follow JS207: new trials by email Literature Review of JS207 trials Research Report on JS207

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors
7MW3711, JS207, Cisplatin - Solid Tumor
Phase 1 / Phase 2RecruitingMabwell (Shanghai) Bioscience Co., Ltd.2802026-02-112026-03-12
Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors
WJ47156, JS001+Bevacizumab, JS207 - Advanced Malignant Solid Tumors
Phase 1Active not recruitingShanghai Junshi Bioscience Co., Ltd.592024-10-232026-07-07
The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of JS207 in Patients With Advanced Malignant Tumor
JS207 - Advanced Malignant Tumor
Phase 1Active not recruitingShanghai Junshi Bioscience Co., Ltd.982023-09-262026-07-02

Sponsors

Shanghai Junshi Bioscience Co., Ltd. (2)  ·  Mabwell (Shanghai) Bioscience Co., Ltd. (1)

Countries

China (3)  ·  Australia (1)